Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4Publishing and Scholarly CommunicationAcademic integrity and plagiarismAcademic Publishing and Open Access

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index; none of the 3 sources its claims cite is checked for support yet.

Toward Structured Transparency: A Governance Framework for AI Use in Biomedical Publishing

Open access
Kim, Jong-Min·2026·Journal of Korean Medical Science

Abstract

The rapid adoption of large language models and generative artificial intelligence (AI) is transforming biomedical research and publishing.Although international organizations such as the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE) have established the principle that AI cannot be recognized as an author, and the ICMJE, in its January 2026 revision, has introduced a dedicated section addressing AI use by authors, peer reviewers, and editors, journal-level Instructions for Authors still require further operational detail to apply these principles consistently throughout the publication process.This review critically examines current AI-related policies in the Journal of Korean Medical Science (JKMS) and the Korean Association of Medical Journal Editors (KAMJE) and identifies three major challenges: the practical limitations of the AI non-authorship principle, the inadequacy of current AI disclosure practices, and the emergence of AI-specific conflicts of interest that extends beyond conventional financial disclosures.We argue that medical publishing should move from a restrictive approach toward a framework of structured transparency that systematically documents, evaluates, and verifies AI use.To achieve this goal, we propose a practical governance framework that includes a three-tiered AI disclosure system, strengthened accountability for corresponding authors, expanded institutional conflict-of-interest disclosures, transparent reporting of AI use by peer reviewers, and formal editorial policies governing AI-assisted editorial activities.Future revisions of the KAMJE and JKMS Instructions for Authors should prioritize transparent and accountable AI governance rather than restricting AI use.Adoption of a structured, publication-wide framework encompassing authors, peer reviewers, and editors would strengthen research integrity while supporting the responsible integration of AI into biomedical publishing.

Overview

CoChat Summary

TL;DR

This review argues that biomedical publishing should move from restrictive AI policies toward structured transparency and proposes a governance framework for authors, peer reviewers, and editors. It analyzes current JKMS and KAMJE AI-related policies and recommends a three-tiered AI disclosure system, strengthened corresponding-author accountability, expanded conflict-of-interest disclosure, reviewer AI disclosure, and editorial AI policies.

Key findings

  • The paper identifies three major challenges: the practical limitations of the AI non-authorship principle, the inadequacy of current AI disclosure practices, and the emergence of AI-specific conflicts of interest that extend beyond conventional financial disclosures.
  • It proposes a three-tiered AI disclosure framework: Tier 1 Assistive (language/grammar/translation/copy-editing/formatting) disclosed in Acknowledgments; Tier 2 Augmentative (AI-assisted drafting, literature synthesis, statistical programming, or analytical support) described in Methods with AI model and version, purpose of prompts, and access dates; Tier 3 Substantive (AI as substitute for human intellectual authorship) prohibited under routine practice, with exceptional cases requiring formal editorial review and independent verification.
  • It recommends that corresponding authors certify all AI-assisted content via an Accountability Clause, that COI disclosure expand to institutional AI interests and collaborations/licensing/data-sharing with AI service providers, that peer reviewers disclose AI use under an analogous tiered framework with Tier 3 prohibited, and that editorial boards establish formal internal policies ensuring human oversight of editorial decision-making.
  • It notes that the ICMJE’s January 2026 revision added a dedicated section on AI use by authors, peer reviewers, and editors, establishing that nondisclosure may in some circumstances be treated as misconduct and that journals should maintain a policy on AI use in review.

Methods

  • Design: critical review and normative governance proposal, not an empirical study.
  • Data or sample: current AI-related Instructions for Authors and policies of the Journal of Korean Medical Science (JKMS) and the Korean Association of Medical Journal Editors (KAMJE), with reference to ICMJE and COPE recommendations.
  • Main analysis: identifies limitations in current guidelines and proposes recommendations for guideline reform, summarized in Table 1.

Limitations

  • Stated limitations: Not stated in the paper.
  • Evident from the text: the proposed framework is not empirically tested or validated, and no implementation data or outcomes are reported.
  • Evident from the text: the analysis focuses on JKMS and KAMJE and the Korean publishing context, although the paper suggests the framework could serve as a practical reference for biomedical journals worldwide.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3346/jkms.2026.41.e318

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 1 Not valid · 3 Not checked · 19 Own results and interpretations

1 more claim

Create a free account to see all 23 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 13

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 6 references

Research works printed but not linked: 1

  1. International Committee of Medical Journal Editors (ICMJE). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Updated 2026. Accessed 2026 July 14. https://www.icmje.org/recommendations/

Metadata

Authors
Kim, J.-M.
Affiliations
Seoul National University (KR)
Corresponding author
Kim, Jong-Min
Venue
Journal of Korean Medical Science
Publisher
XMLink
Published
2026
Volume
41
Issue
29
Pages
e318-e318
ISSN
  • 1011-8934 (ISSN-L)
  • 1598-6357
OpenAlex
W7170179489
Cited by
4
References
6
Citations by year
2026: 4
FWCI
17.80
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • creativecommons.org/licenses/by-nc/4.0/ (tdm)
Locations
  • Journal of Korean Medical Science (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
Topics
  • Social Sciences › Library and Information Sciences › Publishing and Scholarly Communication
  • Social Sciences › Education › Academic integrity and plagiarism
  • Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
Keywords
generative AI, large language models, AI disclosure, conflicts of interest, AI-assisted peer review, research integrity, journal editorial policy, ICMJE, CCOPE, AI governance framework
MeSH terms
Generative Artificial Intelligence, Artificial Intelligence, Authorship, Humans, Publishing, Conflict of Interest, Editorial Policies, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward Structured Transparency: A Governance Framework for AI Use in Biomedical Publishing. https://app.cochat.ai/papers/10.3346/jkms.2026.41.e318
The paper
Kim, J.-M. (2026). Toward Structured Transparency: A Governance Framework for AI Use in Biomedical Publishing. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2026.41.e318

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.